Pharmaceutical manufacturers have been accused, and one has been convicted, of suppressing reports of adverse reactions to their drugs. Last week a major drugmaker pleaded to have such bad news made more widely available.
Dr. Daniel L. Shaw Jr., medical director of Wyeth Laboratories, told the Pharmaceutical Manufacturers’ Asso ciation that reports of adverse reactions now go to the Food and Drug Administration, which compiles them in a monthly review. Relayed to press and public, review items often cause alarm. But they consist largely of unevaluated “raw data”; many of the cases, said Dr. Shaw, have not been checked to make sure whether the patient was indeed taking the drug named, or taking other drugs with it. The FDA, which cannot afford to investigate every case, keeps the names of doctors and patients confidential. This information, suggested Dr. Shaw, should be given to manufacturers—who have the means and the motivation to ferret out the facts.
More Must-Reads from TIME
- Donald Trump Is TIME's 2024 Person of the Year
- Why We Chose Trump as Person of the Year
- Is Intermittent Fasting Good or Bad for You?
- The 100 Must-Read Books of 2024
- The 20 Best Christmas TV Episodes
- Column: If Optimism Feels Ridiculous Now, Try Hope
- The Future of Climate Action Is Trade Policy
- Merle Bombardieri Is Helping People Make the Baby Decision
Contact us at letters@time.com